What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was $5.00 and its highest was $27.90 in the past 12 months.
What is Addex Therapeutics’s market cap?
Currently, no data Available
When is Addex Therapeutics’s upcoming earnings report date?
Addex Therapeutics’s upcoming earnings report date is Apr 18, 2024 which is yesterday.
How were Addex Therapeutics’s earnings last quarter?
Addex Therapeutics released its earnings results on Nov 29, 2023. The company reported -$4.115 earnings per share for the quarter, missing the consensus estimate of -$0.662 by -$3.453.
Addex Therapeutics does not currently pay dividends.
What is Addex Therapeutics’s EPS estimate?
Addex Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Addex Therapeutics have?
Addex Therapeutics has 1,536,287 shares outstanding.
What happened to Addex Therapeutics’s price movement after its last earnings report?
Addex Therapeutics reported an EPS of -$4.115 in its last earnings report, missing expectations of -$0.662. Following the earnings report the stock price went up 0.176%.
Which hedge fund is a major shareholder of Addex Therapeutics?
Among the largest hedge funds holding Addex Therapeutics’s share is New Leaf Venture Partners, L.L.C.. It holds Addex Therapeutics’s shares valued at N/A.
Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.